Twist Bioscience Corp (NASDAQ: TWST) is -13.29% lower on its value in year-to-date trading and has touched a low of $11.46 and a high of $43.21 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TWST stock was last observed hovering at around $31.23 in the last trading session, with the day’s gains setting it 0.73%.
Currently trading at $31.96, the stock is 3.07% and -6.91% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.34 million and changing 2.34% at the moment leaves the stock 15.38% off its SMA200. TWST registered 158.37% gain for a year compared to 6-month gain of 111.94%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -2.92% loss in the last 1 month and extending the period to 3 months gives it a -1.36%, and is 3.93% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.65% over the week and 5.33% over the month.
Twist Bioscience Corp (TWST) has around 919 employees, a market worth around $1.85B and $262.36M in sales. Profit margin for the company is -78.44%. Distance from 52-week low is 178.88% and -26.04% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.85%).
The EPS is expected to grow by 14.54% this year
The shares outstanding are 57.56M, and float is at 55.30M with Short Float at 22.16%.
Twist Bioscience Corp (TWST) Insider Activity
The most recent transaction is an insider sale by Finn Patrick John, the company’s President and COO. SEC filings show that Finn Patrick John sold 2,174 shares of the company’s common stock on Apr 23 ’24 at a price of $30.12 per share for a total of $65483.0. Following the sale, the insider now owns 0.18 million shares.
Twist Bioscience Corp disclosed in a document filed with the SEC on Apr 09 ’24 that Laponis Adam (Chief Financial Officer) sold a total of 556 shares of the company’s common stock. The trade occurred on Apr 09 ’24 and was made at $33.16 per share for $18434.0. Following the transaction, the insider now directly holds 74444.0 shares of the TWST stock.
Still, SEC filings show that on Apr 02 ’24, Leproust Emily M. (Chief Executive Officer) disposed off 1,132 shares at an average price of $32.74 for $37057.0. The insider now directly holds 514,149 shares of Twist Bioscience Corp (TWST).
